Dabur India Limited recalls Med Pride Bacitracin Zinc Ointment due to FDA inspection findings of manufacturing process deviations. Affected lots 022-024, manufactured in India for US distribution.
CGMP Deviations; deficiencies observed during FDA inspection
Dabur India Limited is recalling Med Pride Bacitracin Zinc Ointment tubes because FDA inspections found manufacturing process issues. This recall affects specific lots produced in India for US distribution.
The FDA identified manufacturing process deviations during inspections. These deviations could potentially affect product safety and quality, but the specific risk to consumers isn't clearly described in the recall notice.
Owners of the recalled ointment tubes (72 per case) manufactured for Shield Line LLC in Bayonne, NJ. People using this product for skin care are most at risk if they have the affected lots.
Check for the product name 'Med Pride Bacitracin Zinc Ointment', 1oz tubes, 72 per case. Look for lot numbers 022, 023, or 024 on the packaging. The product was manufactured in India for US distribution.
Look for lot numbers 022, 023, or 024 on the ointment tubes.
FDA inspections found manufacturing process deviations during production.
Lots 022, 023, and 024.
Check for the product name 'Med Pride Bacitracin Zinc Ointment', 1oz tubes, 72 per case, with lot numbers 022, 023, or 024.
The recall notice does not specify a remedy or action for affected products.
We’ve drafted a message you can send Dabur to request your refund or repair — edit it as you like.
Subject: Recall D-0637-2026 — Dabur Dabur Hello, I own a Dabur that is covered by recall D-0637-2026 from Dabur. I’m writing to arrange the remedy described in the recall (a refund, repair, or replacement as applicable). Could you please tell me the next steps to resolve this? Thank you.
Experiences, tips, and questions from readers. Every comment is reviewed before it appears.
No comments yet — be the first to share your experience.
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
